Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · IEX Real-Time Price · USD
3.570
-0.110 (-2.99%)
At close: Jul 19, 2024, 4:00 PM
3.650
+0.080 (2.24%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Atea Pharmaceuticals Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for AVIR.
Analyst Consensus: Sell
Analyst Ratings
According to 1 stock analyst, the rating for AVIR is "Sell". This means that the analyst believes this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 0 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Aug 10, 2023 |
JP Morgan | JP Morgan | Hold Maintains $12 → $8 | Hold | Maintains | $12 → $8 | +124.09% | Mar 16, 2023 |
SVB Leerink | SVB Leerink | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +68.07% | Jan 27, 2023 |
Morgan Stanley | Morgan Stanley | Sell Maintains $7 → $4 | Sell | Maintains | $7 → $4 | +12.04% | Jan 24, 2023 |
Morgan Stanley | Morgan Stanley | Sell Maintains $6 → $7 | Sell | Maintains | $6 → $7 | +96.08% | Aug 15, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
68.66M
EPS This Year
-2.84
from -1.63
EPS Next Year
-3.03
from -2.84
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | 101.5M | 925.3M |
Avg | n/a | 68.7M | 374.1M |
Low | n/a | 37.2M | 93.1M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | 1,247.7% |
Avg | - | - | 444.8% |
Low | - | - | 35.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -2.60 | -2.88 | 0.63 |
Avg | -2.84 | -3.03 | -0.73 |
Low | -3.03 | -3.15 | -1.99 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.